Impaired Bcl3 Up-regulation Leads to Enhanced Lipopolysaccharide-induced Interleukin (IL)-23P19 Gene Expression in IL-10–/– Mice

This publication has 46 references indexed in Scilit:

• A Role for the IκB Family Member Bcl-3 in the Control of Central Immunologic Tolerance
  Immunity, 2007
• Unravelling the pathogenesis of inflammatory bowel disease
  Nature, 2007
• Interleukin-23 drives innate and T cell–mediated intestinal inflammation
  The Journal of Experimental Medicine, 2006
• IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
  Journal of Clinical Investigation, 2006
• STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells
  Blood, 2005
• Interaction Between Resident Luminal Bacteria and the Host: Can a Healthy Relationship Turn Sour?
  Journal of Pediatric Gastroenterology and Nutrition, 2004
• Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
  Nature Medicine, 2002
• Immunological defects in mice with a targeted disruption in Bcl-3.
  Genes & Development, 1997
• Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
  Journal of Clinical Investigation, 1996
• The proto-oncogene bcl-3 encodes an I kappa B protein.
  Genes & Development, 1992